Expression of c-myb and B-myb oncogenes on myelofibrotic marrow fibroblasts

Leukemia and Lymphoma

Volumn 33, Issue 3-4, 1999, Pages 295-304

  Scortechini, Anna Rita ^a   Rupoli, Serena ^b   Piccinini, Gina ^b   Luchetti, Michele Maria ^b   Cantori, Isabella ^b   Gabrielli, Armando ^b   Leoni, Pietro ^b  

^a Ospedale Regionale Torrette   (Italy)

^b NONE

Author keywords

B myb; Bone marrow fibroblasts; c myb; Idiopathic myelofibrosis

Indexed keywords

RNA;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CASE REPORT; CELL PROLIFERATION; CONNECTIVE TISSUE; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; FIBROBLAST; GENE INDUCTION; GENE OVEREXPRESSION; HUMAN; MALE; MYELOFIBROSIS; ONCOGENE; ONCOGENE B MYB; ONCOGENE C MYB; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032942490     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909058429     Document Type: Article

References (36)

1. Ward, H.P., Block, M. H. (1971) The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with myeloproliferative syndrome. Medicine, 50, 357-420.
2. Burstein, S.A., Malpass, T.W., Yee, E., Kadin, M., Brigden, M., Adamson, J.W., Harker, L.A. (1984) Plateled factor-4 excretion in myeloproliferative disease: implication for the aetiology of myelofibrosis. British Journal of Haematology, 57, 383-392.
3. Castro-Malaspina, H. (1984) Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components. In: Berk PD, Castro-Malaspina H Wasserman LR (eds) Myelofibrosis and the biology of connective tissue. Alan R. Liss, INC, New York, 427-454.
4. Bernabei, P.A., Arcangeli, A., Casini. M., Grossi. A., Padovani, R., Ferrini, P.R. (1986) Plateled-derived growth factor(s) mitogenic activity in patients with myeloproliferative disease. British Journal of Haematology, 63, 353-357.
5. Katoh, O., Kimura, A., Kuramoto, A. Plateled-derived growth factors is decreased in patients with myeloproliferative disorders. American Journal of Haematology; 1988, 27, 276-280.
6. Kimura, A., Katoh, O., Kuramoto, A. (1988) Effects of plateled derived growt factor, epidermal growth factors and transforming growth factors B on the growth of human marrow fibroblast. British Journal of Haematology, 69, 9-12.
7. Kimura, A., Katoh, O., Hyodo, H., Kuramoto, A. (1989) Trasforming growth factorB regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. British Journal of Haematology, 72, 486-491.
8. Donald, G., Forrest, P.L., Eastham, J.M., Reilly, J.T. (1991) Reduced plateled PDGF levels in idiopathic myelofibrosis. British Journal of Haematology, 78, 586-588.
9. Martyre, M., Magdelenat, H., Bryckaert, M., Laine-Bidron, C., Calvo, F. (1991) Increased intraplatelet levels of platelet-derived growth factors-B in patients with myelofibrosis with myeloid metaplasia. British Journal of Haematology, 77, 80-86.
10. Hasselbach, H.C. (1993) [diopatic myelofibrosis - an update with particular reference to clinical aspects and prognosis. International Journal of Clinical & Laboratory Research, 23, 124-138.
11. Lüscher, B., Eisenman, R.N. (1990) New light on Myc and Myb. Part II. Myb. Genes & Development, 4, 2235-2241.
12. Mucenski, M.L., McLain, K., Kier, A.B., Swerdlow, S.H., Schreiner, C.M., Miller, T.A., Peitryga, D.W., Scott, W.J. Jr., Porter, S.S. (1991) A functional c-myb is required for normal murine fetal hepatic hematopoiesis. Cell, 65, 677-689.
13. Melani, C., Rivoltini, L., Parmiani, B., Calabretta, B., Colombo, M. (1991) Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Cancer Research, 51, 2897-2901.
14. Hoffman Liebermann, B., Liebermann, D.A. (1991) Suppression of c-Myc and c-myb is tightly linked to terminal differentiation induced by IL-6 or LIF and not growth inhibition in myeloid leukemia cells. Oncogene, 6, 903-909.
15. Selvakumaran, M., Liebermann, D. A., Hoffman Liebermann, B. (1992) Deregulated c-myb disrupts interleukin 6-or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: Role in leukemogenesis. Molecular and Cellular Biology, 12, 2493-2500.
16. Simons, M., Edelman, E.R., Dekeyser, J.L., Langer, R., Rosenberg, R.D. (1992) Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature, 359, 67-70.
17. Szczylik, C., Skorski, T., Ku, D-H., Nicolaides, N.C., Wen, S-C., Rudnicka, L., Bonati, A., Malaguarnera, L., Calabretta, B. (1993) Regulation of Proliferation and Cytokine Expression of Bone Marrow Fibroblasts: Role of c-myb. Journal of Experimental Medicine, 178, 997-1005.
18. Arsura, M., Luchetti, M.M., Erba, E., Golay, J., Rambaldi, A., Introna, M. (1994) Dissociation Between p93 B-myb and p 75 c-myb Expression During the Proliferation and Differentiation of Human Myeloid Cells Lines. Blood, 83, 1778-1790.
19. Introna, M., Luchetti, M., Castellano, M., Arsura, M., Golay, J. (1994) The myb oncogene family of transcription factors: Potent regulators of hematopoietic cell proliferation and differentiation. Seminars in Cancer Biology, 5, 113-124.
20. Nomura, N., Takahashi, M., Matsui, M., Ishii, S., Date, T., Sasamoto, S., Ishizaki, R. (1988) Isolation of human cDNA clones of myb-related genes, A-myb and B-myb. Nucleic Acids Research, 16, 1 1075-1 1089.
21. Reiss, K., Travali, S., Calabretta, B., Barsega, R. (1991) Growth Regulated Expression of B-MYB in fibroblast and Hematopoietic Cell. Journal of Cellular Physiology, 148, 338-343.
22. Arsura, M., Introna, M., Passerini, F., Mantovani, A., Golay, J. (1992) B-myb antisense oligonucleotides inhibit proliferation of human haematopoietic cell lines. Blood, 79, 2708-2716.
23. Sala, A., Calabretta, B. (1992) Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc 2 and cyclin D1 expression. Proceedings of The National Academy of Sciences of The United States of America, 89, 10415-10419.
24. Schultz, A., Knor, H. (1984) Comparative histological and clinical study on the staging of polycythemia vera and osteosclerosis. In: Lennert K, Hubner K (eds) Pathology of the Bone Marrow. Gustav Fisher, Stuttgart, 177-181.
25. Sambrook, J., Fritsch, E.F., Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
26. Belyavsky, A., Vinogradova, T., Rajevsky, K. (1989) Pcr-Based cDNA library construction: general cDNA libraries as the level of a few cells. Nucleic Acids Research, 17, 2919-2932.
27. Olson, J.E., Winston, J.T., Whintlock, J.A., Pledger, W.J. (1993) Cell CycleDependent Gene Expression in V Point-Arrested BALB/c-3T3 cells. Journal of Cellular Physiology, 154, 333-342.
28. Lam, E.W-F., Robinson, C., Watson, R.J. (1992) Characterization and cell cycleregulated expression of mouse B-myb. Oncogene, 7, 1885-1890.
29. Damashek, W. (1951) Some speculations on the myeloproliferative disorders. Blood, 6, 372-375.
30. Jacobson, R.J., Salo, A., Fialkow, P.J. (1978) Agnogenic myeloid metaphasia: a clonal proliferation of haematopoietic stem cells with secondary myelofibrosis. Blood, 51, 189-194.
31. Whang-Peng, J., Lee, E., Knutsen, T., Chang, P., Nienhuis, A. (1978) Cytogenetic studies in patients with myelofibrosis and myeloid metaplasia. Leukaemia Research, 2, 41-56.
32. Castro-Malaspina, H., Gay, R.E., Thanwar, S.L. (1982) Characteristics of bone marrow fibroblast colony forming cells and their progeny in patients with myeloproliferative disorders. Blood, 59, 1046-1056.
33. Groopman, J.E. (1980) The pathogenesis of myelofibrosis in myeloproliferative disorders. Annals of Internal Medicine, 92, 857-865
34. Kimura, A., Katoh, O., Hyodo, H., Kusumi, S., Kuramoto, A. (1991) Autocrine and/or paracrine mechanism operate during the growth of human bone marrow fibroblasts. British Journal of Haematology, 78, 469-473.
35. Piccinini, G., Luchetti, M.M., Caniglia, M.L., Carossino, A.M., Montroni, M., Introna, M., Gabrielli, A. (1996) C-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts and, unlike B-myb gene, does not correlate with proliferation. The Journal of Investigative Dermatology, 106, 1281-1286.
36. Travali, S., Reiss, K., Ferber, A., Petralia, S., Mercer, W.E., Calabretta, B., Baserga, R. (1991) Constitutively expressed c-myb abrogates the requirement for IGF-1 in 3T3 fibroblasts. Molecular and Cellular Biology, 11, 731-736.